Treatment outcomes of infertile women with endometrial hyperplasia undergoing their first IVF/ICSI cycle: A matched-pair study
-
Published:2024-11
Issue:
Volume:302
Page:167-172
-
ISSN:0301-2115
-
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
-
language:en
-
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
Author:
Yang JingORCID,
Lin Mingmei,
Mao Di,
Shan Hongying,
Li Rong
Reference31 articles.
1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022
2. Revising the WHO classification: female genital tract tumours;Cree;Histopathology,2020
3. Zhang YF, Fan Y, Mu Y, Li JK. Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis. J Clin Med. 2023;12.
4. Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N. Oral and intrauterine progestogens for atypical endometrial hyperplasia. Cochrane Database Syst Rev. 2018;12:CD009458.
5. Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature;Yamazawa;Int J Gynecol Cancer,2000